FDA Approves Perrigo's Vaginal Suppositories For Treatment Of Yeast Infections

Michigan-based pharmaceutical company Perrigo, which manufactures nonprescription drugs, on Tuesday announced that it has received FDA approval to sell its terconazole vaginal suppositories for the treatment of yeast infections, Marketwatch reports. Terconazole is the generic version of Ortho McNeil's Terazol 3 vaginal suppositories, an antifungal medication used to treat yeast infections (Marketwatch, 3/21). Perrigo products typically carry store-brand labels (AP/Business Week, 3/21). Shipments of the drug are expected to begin immediately, the company said (Marketwatch, 3/21).


"Reprinted with permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.